C-reactive protein in predicting coronary artery disease in subjects with aortic valve sclerosis before diagnostic coronary angiography

American Journal of the Medical Sciences

Volumn 331, Issue 5, 2006, Pages 264-269

  Hsu, Shun Yi ^a   Hung, Kuo Chun ^b   Chang, Shan Hung ^b   Wen, Ming Shien ^b   Hsieh, I Chang ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Aortic valve sclerosis; Coronary artery disease; High sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCLEROSIS; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGE FACTORS; AGED; AORTIC VALVE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; FEMALE; HEART VALVE DISEASES; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SCLEROSIS;

EID: 33744474049     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200605000-00005     Document Type: Article

References (32)

1. Agmon Y, Khandheria BK, Meissner I, et al. Aortic valve sclerosis and atherosclerosis: different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001;38:827-34.
2. Mohler ER, Sheridan MJ, Nichols R, et al. Development and progression of aortic valve stenosis: atherosclerosis risk factors - a causal relationship? A clinical morphologic study. Clin Cardiol 1991;14:995-9.
3. Lindroos M, Kupari M, Valvanne J, et al. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994;15:865-70.
4. Steward BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcified aortic valve disease: Cardiovascular Healthy Study. J Am Coll Cardiol 1997;29:630-4.
5. Adler Y, Vaturi M, Herz I, et al. Nonobstructive aortic valve calcification: a window to significant coronary artery disease. Atherosclerosis 2002;161:193-7.
6. Jeon DS, Atar S, Brasch AV, et al. Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age ≤65 years old. J Am Coll Cardiol 2001;38:1988-93.
7. Rossi A, Bertagnolli G, Cicoira M, et al. Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation. Clin Cardiol 2003;26:579-82.
8. Hsu SY, Hsieh IC, Chang SH, et al. Aortic valve sclerosis is an echocardiographic indicator of significant coronary disease in patients undergoing diagnostic coronary angiography. Int J Clin Pract 2005;59:72-7.
9. Otto CM, Lind BK, Kitzman DW, et al. Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-7.
10. Chandra HR, Goldstein JA, Choudhary N, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol 2004;43:169-75.
11. Galante A, Pietroiusti A, Vellini M, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1078-82.
12. Pearson TA, Mensah GA, Alexander RW, et al. AHA/CDC Scientific Statement: Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. Circulation 2003;107:499-511.
13. Koenig W, Sund M, Froelich M, et al. C-reactive protein, a sensitive marker of inflammation, predict future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trend and determinants in cardiovascular disease) Augsberg Cohort Study, 1984 to 1992. Circulation 1999;99:237-42.
14. Folsom AR, Pankow JS, Tracy RP, et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001;88:112-7.
15. Kuller LH, Tracy RP, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996;144:537-47.
16. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
17. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
18. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
19. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-82.
20. Danesh J, D.Phil.CB, Wheeler JG, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
21. Principal investigators of CASS and their associates. National Heart, Lung and Blood Institute Coronary Artery Surgery Study. Circulation 1981;63(Suppl):1-41.
22. Roberts WC. The senile cardiac calcification syndrome. Am J Cardiol 1986;58:572-4.
23. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
24. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-53.
25. Wierzbicki A, Shetty C. Aortic stenosis: an atherosclerotic disease? J Heart Valve Dis 1999;8:416-23.
26. O'Brien KD, Shavella DM, Caulfield MT, et al. Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-30.
27. Satta J, Melkko J, Pöllänen R, et al. Progression of human aortic valve stenosis is associated with tenascin-C expression. J Am Coll Cardiol 2002;39:96-101.
28. Jian B, Jones PL, Li Q, et al. Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol 2001;159:321-7.
29. Agmon Y, Khandheria BK, Tajik AJ, et al. Inflammation, infection, and aortic valve sclerosis: insights from the Olmsted County (Minnesota) population. Atherosclerosis 2004;174:337-42.
30. Ortlepp JR, Hoffmann R, Ohme F, et al. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85:635-8.
31. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002;39:695-701.
32. Hak AE, Pols HA, van Hemer AM, et al. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000;20:1926-31.